UBV
KZIA

United Bank (Virginia)’s Kazia Therapeutics KZIA Stock Holding History

United Bank (Virginia)’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Buy
+12,851
New +$157K 0.02% 126
2024
Q4 		– Sell
-880
Closed -$18.9K – 140
2024
Q3 		$18.9K Buy
+880
New +$17.6K ﹤0.01% 140

Other funds holding KZIA

FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

United Bank (Virginia)'s KZIA Position: Q2 2026 in Review

United Bank (Virginia) opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 12,851 shares worth $181K. The stake represents 0.02% of the portfolio and ranks #126 among its holdings. This is a return to the name: United Bank (Virginia) previously reported a position in KZIA as recently as Q3 2024.

United Bank (Virginia) first reported a position in KZIA in Q3 2024 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • United Bank (Virginia) held 12,851 shares of Kazia Therapeutics worth $181K as of Q2 2026.
  • Kazia Therapeutics was a new United Bank (Virginia) position in Q2 2026.
  • Kazia Therapeutics made up 0.02% of United Bank (Virginia)'s portfolio in Q2 2026, its #126 holding.
  • United Bank (Virginia) first reported a position in Kazia Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.